Maree Bilandzic

Maree Bilandzic is an Adjunct Professor at Hudson Institute's Centre for Cancer Research. She specializes in ovarian cancer research focusing on precision medicine, immunotherapy, and tumor biology. Her work contributes to UN Sustainable Development Goals related to health and well-being.

Key Projects:

• Primary Chief Investigator for Therapeutic Targeting of the Leader Cell population in Ovarian Cancer (2019-2022)
• Chief Investigator in Precision Oncology: Directing New Therapeutic Interventions for Ovarian Cancer Patients (2020)

Research interests include cancer stem cell behavior, tumor microenvironment dynamics, and translational applications of immunomodulatory therapies. Her recent studies investigate interferon-ε's tumor suppressive roles and novel diagnostic approaches like the CXCL10 Active Ratio for ovarian cancer detection.

Collaborations span institutions including Australian Ovarian Cancer Study Group and international research networks. Her work has been featured in Nature and other high-impact journals, with notable media coverage of breakthrough findings.